Scott Clifford Borland, Age 641976 E Woodland Dr, Akron, OH 44313

Scott Borland Phones & Addresses

Akron, OH

Broadview Heights, OH

Mansfield, OH

Santa Clara, CA

Wexford, PA

1216 Saint Charles Ave, Lakewood, OH 44107 (216) 288-5226

Social networks

Scott Clifford Borland

Linkedin

Work

Position: Professional/Technical

Education

Degree: Graduate or professional degree

Emails

Mentions for Scott Clifford Borland

Scott Borland resumes & CV records

Resumes

Scott Borland Photo 24

Scott Borland

Location:
United States

Publications & IP owners

Wikipedia

Scott Borland Photo 25

Scott Borland

Scott Borland is a musician from the United States. He is the founder of the band Big Dumb Face and a past member of Limp Bizkit He is the brother of Wes Borland.

Us Patents

Aperture Plate And Methods For Its Construction And Use

US Patent:
7066398, Jun 27, 2006
Filed:
Mar 30, 2001
Appl. No.:
09/822573
Inventors:
Scott Borland - San Mateo CA, US
Gary Baker - Mountain View CA, US
Assignee:
Aerogen, Inc. - San Carlos CA
International Classification:
B05B 1/08
US Classification:
2391022, 239559, 239567, 239601
Abstract:
A method for performing an aperture plate comprises providing a mandrel that is constructed of a mandrel body having a conductive surface and a plurality of nonconductive islands disposed on the conductive surface. The mandrel is placed within a solution containing a material that is to be deposited onto the mandrel. Electrical current is applied to the mandrel to form an aperture plate on the mandrel, with the apertures having an exit angle that is in the range from about 30 to about 60.

Aperture Plate And Methods For Its Construction And Use

US Patent:
8398001, Mar 19, 2013
Filed:
Jun 19, 2006
Appl. No.:
11/471282
Inventors:
Scott Borland - San Mateo CA, US
Gary Baker - Mountain View CA, US
Assignee:
Novartis AG - Basel
International Classification:
B05B 17/04
US Classification:
239 4, 2391021, 239567, 239601
Abstract:
A method for performing an aperture plate comprises providing a mandrel that is constructed of a mandrel body having a conductive surface and a plurality of non-conductive islands disposed on the conductive surface. The mandrel is placed within a solution containing a material that is to be deposited onto the mandrel. Electrical current is applied to the mandrel to form an aperture plate on the mandrel, with the apertures having an exit angle that is in the range from about 30 to about 60.

Laminated Electroformed Aperture Plate

US Patent:
2002012, Sep 5, 2002
Filed:
Oct 2, 2001
Appl. No.:
09/970335
Inventors:
Scott Borland - San Mateo CA, US
Jonathan Martin - Sunnyvale CA, US
Scott Semans - Sunnyvale CA, US
Assignee:
AEROGEN, INC.
International Classification:
A61M011/00
A61M015/00
US Classification:
128/200160, 128/200140, 128/203120
Abstract:
An aperture plate comprises a plate body having a top surface, a bottom surface, and tapered walls that form a plurality of apertures that taper from the bottom surface to the top surface wherein the plate body comprises a base material and a corrosion resistive material plating at least the tapered walls. The aperture plate can be produced by electroplating a mandrel wherein the mandrel is placed within a solution containing a material that is to be deposited onto the mandrel. Electrical current is applied to the mandrel to form the aperture plate on the mandrel. The process can be repeated so as to deposit a second layer, such as a corrosion resistive material, over a base layer material. In such fashion, a laminated electroformed aperture plate can be produced.

Hand-Held, Low-Flow Therapeutic Gas Dispensers

US Patent:
2008016, Jul 17, 2008
Filed:
Jan 17, 2007
Appl. No.:
11/624140
Inventors:
Ryan Connolly - Menlo Park CA, US
Edward Cooper - Lafayette CA, US
Brian Lamb - San Francisco CA, US
Scott Borland - Santa Clara CA, US
Assignee:
CAPNIA, INCORPORATED - Palo Alto CA
International Classification:
B65B 31/00
US Classification:
141 19
Abstract:
A hand-held, low-flow dispenser comprises an enclosure holding a gas cartridge. A spring-biased needle is advanced to puncture a septum on the gas cartridge, and a separate spring-biased ball valve is used to turn the resulting gas flow off and on as well as to control the flow rate.

Administration Of Dihydroergotamine Mesylate Particles Using A Metered Dose Inhaler

US Patent:
2011017, Jul 14, 2011
Filed:
Jun 25, 2010
Appl. No.:
12/823981
Inventors:
Donald J. KELLERMAN - San Jose CA, US
Shashidhar H. Kori - Dublin CA, US
Scott W. Borland - Santa Clara CA, US
Thomas A. Armer - Cupertino CA, US
International Classification:
A61K 9/12
A61P 25/00
US Classification:
424 45
Abstract:
Disclosed are compositions of matter and related methods that provide a metered dose inhaler that includes a formulation having a dose that comprises a hydrofluoroalkane propellant and dihydroergotamine mesylate particles; wherein the dose includes between 0.1 mg to 4 mg of dihydroergotamine mesylate; wherein the dihydroergotamine mesylate particles have a cumulative drug substance particle size distribution with d10>0.5 micron volumetric median diameter and d90

Method For The Construction Of An Aperture Plate For Dispensing Liquid Droplets

US Patent:
6235177, May 22, 2001
Filed:
Sep 9, 1999
Appl. No.:
9/392180
Inventors:
Scott Borland - San Mateo CA
Gary Baker - Mountain View CA
Assignee:
Aerogen, Inc. - Sunnyvale CA
International Classification:
C25D 100
C25D 502
US Classification:
205 67
Abstract:
A method for forming an aperture plate comprises providing a mandrel that is constructed of a mandrel body having a conductive surface and a plurality of non-conductive islands disposed on the conductive surface. The mandrel is placed within a solution containing a material that is to be deposited onto the mandrel. Electrical current is applied to the mandrel to form an aperture plate on the mandrel, with the apertures having an exit angle that is in the range from about 30. degree. to about 60. degree.

Ergoline Compounds And Uses Thereof

US Patent:
2021011, Apr 22, 2021
Filed:
May 26, 2020
Appl. No.:
16/883920
Inventors:
- Los Gatos CA, US
Geoff McKinley - Los Gatos CA, US
Scott Borland - Los Gatos CA, US
Miguel Guzman - Los Gatos CA, US
Armin Szabolcs - Szombathely, HU
Janos Gerencser - Budapest, HU
International Classification:
C07D 471/06
C07D 495/06
Abstract:
Provided herein are ergoline compounds and pharmaceutical compositions thereof. In some embodiments, provided herein are methods of treatment, prevention, or amelioration of a variety of medical disorders such as, for example, migraine using the compounds and pharmaceutical compositions disclosed herein. In still other embodiments, provided herein are methods of agonizing receptors such as, for example, the 5-HT, 5-HTand 5-HTreceptors without agonizing the 5-HTreceptor using the compounds and pharmaceutical compositions disclosed herein. In still other embodiments, provided herein are methods of antagonizing the 5-HTadrenergic alphaand/or the alphareceptors using the compounds and pharmaceutical compositions disclosed herein. In still other embodiments, provided herein are methods of antagonizing the D2 and D3 receptor using the compounds and pharmaceutical compositions disclosed herein.

Ergoline Compounds And Uses Thereof

US Patent:
2019033, Nov 7, 2019
Filed:
Apr 10, 2019
Appl. No.:
16/380706
Inventors:
- Los Gatos CA, US
Scott Borland - Los Gatos CA, US
Miguel Guzman - Los Gatos CA, US
Armin Szabolcs - Szombathely, HU
Janos Gerencser - Budapest, HU
International Classification:
C07D 471/06
C07D 495/06
Abstract:
Provided herein are ergoline compounds and pharmaceutical compositions thereof. In some embodiments, provided herein are methods of treatment, prevention, or amelioration of a variety of medical disorders such as, for example, migraine using the compounds and pharmaceutical compositions disclosed herein. In still other embodiments, provided herein are methods of agonizing receptors such as, for example, the 5-HT, 5-HTand 5-HTreceptors without agonizing the 5-HTreceptor using the compounds and pharmaceutical compositions disclosed herein. In still other embodiments, provided herein are methods of antagonizing the 5-HTadrenergic alphaand/or the alphareceptors using the compounds and pharmaceutical compositions disclosed herein. In still other embodiments, provided herein are methods of antagonizing the D2 and D3 receptor using the compounds and pharmaceutical compositions disclosed herein.

NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.